Saturday, April 15, 2006 1:14:24 PM
On infringement:
5 features: read request with precharge, DLL, access time reg, variable block size, data out in response to rising and falling edge clock
Read request with auto precharge: H states there’s only one kind of read. But there’s a read command and a read with auto precharge command. Two different commands. In addition, the read with auto precharge data output cannot be interrupted.
Access Time Reg: Changing the command, changes the delay. From Lee:
Cas = 2, data must wait at least 1 clock cycle.
Cas = 3, data must wait at least 2 clock cycles
Taylor: Cas = 2, data must wait 1 clock cycle + tAC.
DLL: On chip DLL. Dispute over variable delay line. The H schematic shows DLL. The internal training manual schematic shows DLL. H states they use a tap select line. 3 different roads to SF (Hynix example repeated). [actually, the different 3 roads to SF is not a valid tap-select example that Hynix used. In select tap, the exact same road is used. If you want a longer delay, the road traveled becomes a bit longer. Hynix’s example is very flawed and should have been pointed out.] Stone reminds the jury of the DLL patent (don’t know who it belongs to, nor is it important). It’s defined as a DLL patent, yet it shows a tap delay line (just what Hynix has).
Data out in response to rising and falling edge of clock: That’s how it’s stated in H datasheet. Hynix maintains not rising edge, but crossing point. [just semantics] Stone refers back to Taylor’s technical report where he states: Data out on every edge of clock.
‘105 patent- coupled to – output driver to clock. Dispute: Taylor says the circuit signal (which is a clock signal) changes names. But the circuit displays a cause and effect. Stone questions why you can’t change name more than 2 OR 3 times? Stone provides 2 examples of coupling. [I notice in a previous post I had attributed the cell phone example to Furniss. This was incorrect.] Cell phone connection with brother. The speech goes through a number of components: phone, transmitter, switching station, etc. All these components are coupled together so that they can communicate together. A second example of the gas pedal coupled to the back tires is given. Murphy explained coupling. When the clock wiggles here, the output wiggles there. That’s coupling. That’s infringement!
On Damages:
Teece provided a hypothetical negotiation for royalty rates. It was a conservative calculation. Very conservative. Didn’t take things into account. 1. Untested patents. 2. World Wide license. Stone repeats jury instruction: Financial position should be as if no infringement occurred but not less. (something to that effect) Weinstein didn’t disagree with Teece’s numbers. This case will eliminate the patent uncertainty. The 50% uncertainty is removed. Damages should be increased by a factor of 2. $4.4B US sales only- What effect does that have when other agreements are on world wide sales? Teece said an adjustment is needed. 2 or 3 times higher, probably not 4. Weinstein didn’t disagree. When uncertainty is removed, damages should be: SDRAM $25M, DDR $192M. When WW sales is accounted for damages should be: SDRAM $100M, DDR $768M. [Looks like Stone pretty much used a factor of 4]
Wrap up:
This case is about choices, values. Innovation to benefit all of us.
We reward inventions. That’s why we have a patent law.
H takes 6 years to bring this to resolution. They want to preserve their market share.
Their approach is don’t pay R. Drag out negations and sue.
Recent RMBS News
- Rambus Reports First Quarter 2024 Financial Results • Business Wire • 04/29/2024 08:05:00 PM
- Rambus Expands Chipset for Advanced Data Center Memory Modules with DDR5 Server PMICs • Business Wire • 04/29/2024 08:02:00 PM
- U.S. Futures Rise in Pre-Market Trading Amid Key Federal Reserve Meeting and Earnings Week Ahead • IH Market News • 04/29/2024 11:12:54 AM
- Rambus to Announce First Quarter Fiscal Year 2024 Results • Business Wire • 04/08/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:05:25 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/08/2024 09:10:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/08/2024 09:05:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/08/2024 09:02:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 06:36:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:06:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 06:26:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:34:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 05:48:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:21:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 09:18:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:55:31 PM
- Rambus Initiates Accelerated Share Repurchase Program • Business Wire • 03/01/2024 01:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 06:04:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 07:22:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:28:08 PM
- Rambus to Present at Morgan Stanley Technology, Media & Telecom Conference • Business Wire • 02/20/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:08:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2024 09:06:56 PM
- Futures Pointing To Initial Strength On Wall Street • IH Market News • 02/07/2024 02:12:55 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM